norepinephrine/serotonin reuptake inhibitors (Theravance)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namenorepinephrine/serotonin reuptake inhibitors (Theravance)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNorepinephrine reuptake inhibitorsSerotonin reuptake inhibitors
TargetsNorepinephrine transporterSerotonin transporter
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInnoviva Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnoviva Inc
Active IndicationsN/A
Inactive IndicationsCentral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A